Literature DB >> 6471269

Papanicolaou smear screening and cervical cancer. What can you expect?

B Stenkvist, R Bergström, G Eklund, C H Fox.   

Abstract

More than 90% of the total female population of three Swedish counties between the ages of 30 and 59 years, 53% of women between 60 and 69 years, and 25% of women older than 70 years were screened for cervical cancer with the Papanicolaou smear over a ten-year period. The uniqueness of the study is that in Sweden it is possible to follow up the entire population during their lifetimes via a population register, which has its roots in the 17th century, natural to Swedes but almost incomprehensible in the United States or United Kingdom. Every Papanicolaou smear taken was computer recorded and linked on an individual level to the cancer registry. There were 207,455 women followed up for ten years. No women were lost to follow-up. There was a 75% decrease in invasive cervical cancer incidence among women who had smears taken at least once during the ten-year period. Among those women who had never had smears taken, the incidence of invasive cervical cancer was four times as great as among those women who had been examined at least once. We estimate that the system proposed by Swedish Medical Board (at least one smear every three years) for cervical cancer screening can reduce the incidence of invasive cervical cancer to a level between one and five cases per 100,000 women per year in a completely screened population.

Entities:  

Mesh:

Year:  1984        PMID: 6471269

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Person-years of life lost due to cancer in the United States, 1970 and 1984.

Authors:  J W Horm; E J Sondik
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

2.  Preventive Care for the Elderly: Uncovering the unmet needs of this population.

Authors:  L Mallery; K Rockwood
Journal:  Can Fam Physician       Date:  1992-10       Impact factor: 3.275

3.  Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

4.  Development of a community cancer education program: the Forsyth County, NC cervical cancer prevention project.

Authors:  R Michielutte; M B Dignan; H B Wells; L D Young; D S Jackson; P C Sharp
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

5.  The pap smear and cervical cancer screening.

Authors:  T J Elmslie
Journal:  Can Fam Physician       Date:  1987-01       Impact factor: 3.275

6.  An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany.

Authors:  Sara K Sheriff; K Ulrich Petry; Hans Ikenberg; Geoffrey Crouse; Peter D Mazonson; Christopher C Santas
Journal:  Eur J Health Econ       Date:  2007-02-17

Review 7.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

8.  Improving future preventive care through educational efforts at a women's community screening program.

Authors:  P Carney; A J Dietrich; D H Freeman
Journal:  J Community Health       Date:  1992-06

9.  Liquid-based cytology for primary cervical cancer screening: a multi-centre study.

Authors:  J Monsonego; A Autillo-Touati; C Bergeron; R Dachez; J Liaras; J Saurel; L Zerat; P Chatelain; C Mottot
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

10.  Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.

Authors:  L Gustafsson; H O Adami
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.